drugset
drugset / Trial / NCT03549208

A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults

NCT03549208 ↗

Phase 1 Unknown 60 enrolled LG Chem
RandomizedParallel-groupSingle-blindPrevention

Summary

phase-1 study pneumococcal conjugate vaccine study in healthy adults

Timeline

Start
2018-07-01
Primary completion
2019-04-01
Completion
2019-07-25

Drugs

EvaluationDrugModalityDoseRoute
Subject LBVE01 Unknown — Intramuscular
Subject LBVE02 Unknown — Intramuscular
Comparator Prevnar 13 Vaccine — Intramuscular

Indications

pneumococcal infection